CME Group
Operates global derivatives exchanges, clearing, and electronic fixed-income and foreign-exchange markets.
Something off on this page? Send us feedback.
Profile
Operates futures and options exchanges across interest rates, equity indexes, currencies, agriculture, energy, metals and cryptocurrencies, alongside BrokerTec fixed-income and EBS foreign-exchange markets. Most revenue comes from transaction and clearing fees, supported by market data subscriptions and benchmark licensing.
Runs futures and options markets through CME, CBOT, NYMEX and COMEX, spanning interest rates, equity indexes, foreign exchange, agriculture, energy, metals and cryptocurrencies. CME Globex handles most electronic trading, while CME Clearing stands between buyers and sellers and manages margin and settlement.
Extends beyond listed derivatives through BrokerTec for cash government bonds and repo, EBS for spot and over-the-counter foreign exchange, and services for market data, analytics and benchmarks. Pairing benchmark contracts with integrated clearing helps participants manage risk and margin across portfolios.
Earns most revenue from transaction and clearing fees, supplemented by data subscriptions, access fees and benchmark licensing. Trading demand moves with market volatility and hedging activity, while regulated exchanges, clearing houses and cash-market venues operate across the United States, United Kingdom and European Union.
Company facts
Key statistics
Year to date +6.0% · Average volume (30d) 2.1M
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Prior rating | Rating | Prior target | Target |
|---|---|---|---|---|---|---|
| Aug 19, 2026 | Deutsche Bank | Downgrade | Buy | Hold | $300 | $270 |
| Jul 23, 2026 | Morgan Stanley | Reiterate | Overweight | $324 | $330 | |
| Jul 15, 2026 | Piper Sandler | Reiterate | Overweight | $320 | $295 | |
| Jul 10, 2026 | Morgan Stanley | Reiterate | Overweight | $353 | $324 | |
| Jul 6, 2026 | UBS | Reiterate | Buy | $310 | $260 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Jul 22, 2026Q2 FY26 | $2.91 | $2.99 | +2.7% | $1.68B | $1.71B | +1.4% | +2.04% |
| Apr 22, 2026Q1 FY26 | $3.34 | $3.36 | +0.6% | $1.87B | $1.88B | +0.3% | −0.08% |
| Feb 4, 2026Q4 FY25 | $2.75 | $2.77 | +0.7% | $1.65B | $1.65B | +0.1% | +0.94% |
| Oct 22, 2025Q3 FY25 | $2.63 | $2.68 | +1.9% | $1.53B | $1.54B | +0.5% | +0.41% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $1.64B | $1.69B | $1.54B | $1.65B | $1.88B | $1.71B | |
| Gross profit | $1.44B | $1.47B | $1.30B | $1.41B | $1.66B | $1.18B | |
| Operating income | $1.11B | $1.13B | $972.6M | $1.02B | $1.31B | $1.11B | |
| Net income | $956.2M | $1.01B | $908.0M | $1.17B | $1.15B | $1.04B | |
| Diluted EPS | $2.62 | $2.81 | $2.49 | $3.24 | $3.18 | $2.88 | |
| Gross margin | 87.4% | 86.9% | 84.5% | 85.4% | 88.1% | 69.2% | |
| Operating margin | 67.5% | 66.7% | 63.3% | 61.8% | 69.7% | 64.9% |
Fiscal years (4-quarter sums)FY21 $4.69B · FY22 $5.02B · FY23 $5.58B · FY24 $6.13B · FY25 $6.52B
Revenue by product · Q2 FY26
Balance sheet, Jun 30, 2026Cash & short-term investments $2.28B · Total debt $3.42B · Total assets $194.68B · Shareholders' equity $26.52B
Dividends
Raised for 22 straight years — most recently to $1.30 from $1.25 in Jun 2026. To collect a payout, hold shares through the close before the ex-date.
History
| Ex-date | Record | Paid | Amount | Note |
|---|---|---|---|---|
| Jun 9, 2026 | Jun 9 | Jun 25 | $1.30 | raised from $1.25 |
| Mar 10, 2026 | Mar 10 | Mar 26 | $7.45 | special dividend |
| Dec 12, 2025 | Dec 12 | Dec 30 | $1.25 | |
| Sep 9, 2025 | Sep 9 | Sep 25 | $1.25 | |
| Jun 9, 2025 | Jun 9 | Jun 25 | $1.25 | |
| Mar 7, 2025 | Mar 7 | Mar 26 | $1.25 | raised from $1.15 |
| Dec 27, 2024 | Dec 27 | Jan 16 | $5.80 | special dividend |
| Dec 9, 2024 | Dec 9 | Dec 27 | $1.15 |
Ownership
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 359.58M · Float 354.62M · 98.6% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 30.57M | 8.50% | 13F | Aug 7, 2026 |
| Vanguard Capital Management LLC | 23.66M | 6.58% | 13F | Aug 13, 2026 |
| State Street Corp | 16.35M | 4.55% | 13F | Aug 7, 2026 |
| Morgan Stanley | 9.73M | 2.71% | 13F | Aug 13, 2026 |
| Geode Capital Management, LLC | 9.27M | 2.58% | 13F | Aug 12, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Jun 25, 2026 | William R. Shepard | director | +339 | $230.57 |
| May 18, 2026 | Hilda Harris Piell | officer: Sr MD & Chief HR Officer | −5,753 | $304.63 |
| May 15, 2026 | Terrence A. Duffy | director, officer: Chairman and CEO | −35,000 | $298.51 |
| Mar 26, 2026 | William R. Shepard | director | +1,470 | $297.38 |
| Mar 17, 2026 | Jonathan L. Marcus | officer: Sr MD General Counsel | −6,582 | $323.37 |
Peers
- Intercontinental Exchange
Closest US peer: energy, agricultural, financial futures, clearing, and data.
- Cboe Global Markets
Dominant US equity-index and volatility options; VIX/SPX vs CME equity futures.
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| CME Group | $269.56 | −5.68% | $102.77B | 24.2 | 23.0 | 15.2 | +0.8% |
| Intercontinental Exchange | $162.37 | +0.02% | $91.13B | 22.9 | 19.7 | 6.8 | −18.3% |
| Cboe Global Markets | $310.51 | −0.05% | $32.49B | 24.2 | 21.8 | 6.4 | −37.7% |
| Median | 23.6 | 20.8 | 6.6 | −28.0% |